Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 139,400 shares, an increase of 26.3% from the March 15th total of 110,400 shares. Based on an average trading volume of 143,900 shares, the short-interest ratio is currently 1.0 days. Approximately 0.4% of the company's stock are short sold.
Crescent Capital BDC Stock Up 0.5 %
NASDAQ CCAP traded up $0.08 on Friday, reaching $16.06. The company had a trading volume of 54,271 shares, compared to its average volume of 143,046. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $595.22 million, a P/E ratio of 8.07 and a beta of 0.56. The company's fifty day moving average is $16.87 and its 200 day moving average is $18.34. Crescent Capital BDC has a 52-week low of $13.54 and a 52-week high of $20.19.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. Sell-side analysts anticipate that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.
Crescent Capital BDC Announces Dividend
The firm also recently announced a dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's dividend payout ratio is presently 84.42%.
Institutional Trading of Crescent Capital BDC
A number of institutional investors and hedge funds have recently modified their holdings of CCAP. Raymond James Financial Inc. bought a new position in Crescent Capital BDC in the 4th quarter valued at $3,750,000. Franklin Resources Inc. raised its position in Crescent Capital BDC by 35.2% in the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock worth $4,726,000 after acquiring an additional 66,713 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Crescent Capital BDC in the fourth quarter valued at about $661,000. Redhawk Wealth Advisors Inc. bought a new position in shares of Crescent Capital BDC during the 4th quarter valued at approximately $659,000. Finally, Stifel Financial Corp increased its stake in shares of Crescent Capital BDC by 53.1% during the 3rd quarter. Stifel Financial Corp now owns 66,470 shares of the company's stock worth $1,230,000 after purchasing an additional 23,055 shares during the last quarter. 49.46% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Keefe, Bruyette & Woods lowered their target price on Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a report on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Crescent Capital BDC currently has an average rating of "Moderate Buy" and a consensus target price of $18.90.
View Our Latest Report on Crescent Capital BDC
About Crescent Capital BDC
(
Get Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.